Literature DB >> 10919020

Prognostic significance of the carcinoma area in the thickest part of the lymph node.

N Doi1, T Imada, N Aoyama, Y Kameda, H Koizumi.   

Abstract

BACKGROUND/AIMS: The carcinoma volume in each metastatic lymph node varies widely. Our aim was to define the meaning of carcinoma volume in lymph nodes as a prognostic factor.
METHODOLOGY: One hundred and five patients with preoperatively untreated esophageal carcinoma who underwent surgery were enrolled as subjects. In the present study, the carcinoma area within lymph nodes at their thickest level was substituted for carcinoma volume in lymph nodes for measurement and analysis. A total of 3,703 lymph nodes were isolated and the area of the carcinoma in the thickest part of the lymph node (CALN) was measured. Univariate and multivariate analysis of prognostic significance were made for the factors age, sex, cancer location, cell differentiation, pT, conventional classification of lymph nodes for surgical dissection (n), number of metastatic lymph nodes (MLN number), and CALN.
RESULTS: In all 105 cases, n was the best prognostic factor and CALN was more useful than MLN number. In the cases in which absolute curative resection was successful, CALN was the best prognostic factor.
CONCLUSIONS: The carcinoma area in the thickest part of the lymph node is a meaningful prognostic factor.

Entities:  

Mesh:

Year:  2000        PMID: 10919020

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Authors:  O Cheong; S T Oh; B S Kim; J H Yook; J H Kim; J T Im; G C Park
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

2.  Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases?

Authors:  Stephen McGrath; Sarah Cross; Susan Anne Pritchard
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

3.  18F-fluorodeoxyglucose positron emission tomography/computed tomography for the prediction of survival in patients with advanced esophageal cancer who have undergone neoadjuvant chemotherapy.

Authors:  Masahiko Yano; Hiroshi Miyata; Keijiro Sugimura; Masaaki Motoori; Takeshi Omori; Yoshiyuki Fujiwara; Norikatsu Miyoshi; Masayoshi Yasui; Masayuki Ohue; Hirofumi Akita; Akira Tomokuni; Hidenori Takahashi; Shogo Kobayashi; Masato Sakon
Journal:  Mol Clin Oncol       Date:  2018-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.